Immuneering (IMRX) Shares Issued (2021 - 2024)
Historic Shares Issued for Immuneering (IMRX) over the last 4 years, with Q4 2024 value amounting to $3.5 million.
- Immuneering's Shares Issued rose 4415707.72% to $3.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.2 million, marking a year-over-year increase of 84416.39%. This contributed to the annual value of $4.2 million for FY2024, which is 84416.39% up from last year.
- According to the latest figures from Q4 2024, Immuneering's Shares Issued is $3.5 million, which was up 4415707.72% from $732458.0 recorded in Q1 2024.
- Over the past 5 years, Immuneering's Shares Issued peaked at $119.4 million during Q3 2021, and registered a low of -$27.8 million during Q3 2023.
- Moreover, its 4-year median value for Shares Issued was $193111.0 (2022), whereas its average is $11.3 million.
- Data for Immuneering's Shares Issued shows a peak YoY increase of 10053559.96% (in 2023) and a maximum YoY decrease of 7436041.83% (in 2023) over the last 5 years.
- Immuneering's Shares Issued (Quarter) stood at $119.4 million in 2021, then crashed by 99.96% to $42098.0 in 2022, then tumbled by 81.39% to $7835.0 in 2023, then soared by 44157.08% to $3.5 million in 2024.
- Its Shares Issued was $3.5 million in Q4 2024, compared to $732458.0 in Q1 2024 and $7835.0 in Q4 2023.